Gemini Therapeutics Inc
Biotechnology
Healthcare
GMTX
43.23 M shares
NASDAQ US
traded
28 Dec 2022
listed
yes
open
1.23
52 week high
3.08
high
1.36
52 week low
1.32
previous Close
1.35
P/E ratio
market cap
70.92 M
div yield
0
net incoming
-7.09 M
53.45 %
net profit margin
-709000000.00 %
0.00 %
operating incoming
-7.23 M
52.34 %
net change in cash
-10.73 M
38.92 %
cash on hand
109 M
-8.74 %
top